BPC-157: The Gastric-Derived Healer BPC-157 (Body Protection Compound) is a 15-amino acid peptide
It concluded: "There is a strong indication that GLP-1 receptor agonists may have a useful role in future treatment of Parkinson's disease." Of note, both trials had a washout period after the drug treatment ended and the benefit for motor symptoms persisted
Some people also use BPC 157 Peptides for: Ulcers in the stomach Intestinal damage (such as fistulas) Inflammatory disorders Bone and Joint healing growth rates Organ Damage Treatment for Celiacs and Crohns disease Research and Future Directions While research on BPC 157 Peptides continues to evolve, early studies have highlighted its potential in multiple mechanisms of action
- At least one in 10 Americans is now on a GLP-1 weight loss drug, medications already credited with helping people lose weight and reduce their risk of diabetes and cardiovascular disease
Some companies, including Lilly, are also exploring oral GLP-1 receptor agonists, which DIMarchi refers to as small molecule mimetrics. These molecules, however, are far more complex than traditional oral small molecules
Already approved for prescription in Europe, USA, Canada, Australia, Japan and Switzerland, orally administered semaglutide has been shown to be effective, safe and well tolerated